Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Net Income: 2011-2024

Historic Net Income for Adma Biologics (ADMA) over the last 11 years, with Dec 2024 value amounting to $197.7 million.

  • Adma Biologics' Net Income rose 1.45% to $36.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $209.4 million, marking a year-over-year increase of 207.41%. This contributed to the annual value of $197.7 million for FY2024, which is 800.00% up from last year.
  • According to the latest figures from FY2024, Adma Biologics' Net Income is $197.7 million, which was up 800.00% from -$28.2 million recorded in FY2023.
  • Over the past 5 years, Adma Biologics' Net Income peaked at $197.7 million during FY2024, and registered a low of -$76.6 million during FY2020.
  • Over the past 3 years, Adma Biologics' median Net Income value was -$28.2 million (recorded in 2023), while the average stood at $34.5 million.
  • Data for Adma Biologics' Net Income shows a peak YoY surged of 800.00% (in 2024) over the last 5 years.
  • Adma Biologics' Net Income (Yearly) stood at -$76.6 million in 2020, then climbed by 6.81% to -$71.4 million in 2021, then grew by 7.69% to -$65.9 million in 2022, then soared by 57.15% to -$28.2 million in 2023, then spiked by 800.00% to $197.7 million in 2024.